X0306 4 2019-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001566080 Ballinger Kevin J. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & Pres, Interven Cardio Common Stock 2018-11-06 5 G 0 2385.0000 0.0000 D 69623.0000 D Common Stock 2019-01-01 4 M 0 21502.0000 0.0000 A 91125.0000 D Common Stock 2019-01-01 4 F 0 6762.0000 35.3400 D 84363.0000 D Performance Share Units 0.0000 2019-01-01 4 M 0 21502.0000 0.0000 D 2018-12-31 2018-12-31 Common Stock 21502.0000 0.0000 D Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ends on December 31, 2018. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. ballingerpoa.txt /s/ Vance R. Brown, Attorney-in-fact 2019-01-03